Last €110.00 EUR
Change Today +1.82 / 1.68%
Volume 1.9K
As of 11:35 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

pharmagest interactive (PHA) Snapshot

Open
€108.17
Previous Close
€108.18
Day High
€112.00
Day Low
€107.76
52 Week High
04/8/14 - €117.00
52 Week Low
04/19/13 - €67.80
Market Cap
333.8M
Average Volume 10 Days
1.8K
EPS TTM
€5.22
Shares Outstanding
3.0M
EX-Date
--
P/E TM
21.1x
Dividend
€2.50
Dividend Yield
1.91%
Current Stock Chart for PHARMAGEST INTERACTIVE (PHA)

Related News

No related news articles were found.

pharmagest interactive (PHA) Related Businessweek News

No Related Businessweek News Found

pharmagest interactive (PHA) Details

Pharmagest Interactive Societe Anonyme provides IT solutions for pharmacies in France, Belgium, and Luxembourg. The company offers LGPI Global Services software that serves as a notoriety and point of sale loyalty building tool; and software packages for dispensing pharmacies, such as SABCO New software, SABCO Optimum software, and SABCO Ultimate software. Its solutions include OFFILEARNING, an e-learning product; OFFIZZY, a payment solution, which allows the SESAM-Vitale cards to be updated directly at the counter; and Offimédia products, as well as price information terminals. It also provides SELLEN counter robots; DO-Pill SecuR, an intelligent electronic pill dispenser; artificial intelligence and expert systems to predict the evolution of the state of health of patients; Offisecure, an Internet service provider product; TELE100T, a service for hosting personal health data through infrastructure platform DATA100T aiming at hosting medical data and applications; and Pharmattitude Website. In addition, it is involved in developing software solutions for care homes and day centers; and outsourcing of back-ups for health professionals, pharmacists, or health institutions. The company was incorporated in 1996 and is based in Villers-lès-Nancy, France. Pharmagest Interactive Societe Anonyme is a subsidiary of Welcoop Pharma.

750 Employees
Last Reported Date: 08/27/13
Founded in 1996

pharmagest interactive (PHA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pharmagest interactive (PHA) Key Developments

Pharmagest Interactive Announces Audited Consolidated Earnings Results for the Year 2013

Pharmagest Interactive announced audited consolidated earnings results for the year 2013. For the year, the company reported turnover of €113.41 million against €108.72 million a year ago. Operating income was €23.12 million against €20.14 million a year ago. Net income was €15.83 million against €13.90 million a year ago. Net income - group share was €15.83 million or €5.22 per basic share against €13.52 million or €4.45 per basic share a year ago.

Pharmagest Interactive Societe Anonyme, Board Meeting, Mar 27, 2014

Pharmagest Interactive Societe Anonyme, Board Meeting, Mar 27, 2014. Agenda: To approve the accounts for the financial year 2013.

Pharmagest Interactive Societe Anonyme Reports Unaudited Sales Results for the Year Ended December 31, 2013; Provides Earnings Guidance for the Year 2013 and 2014

Pharmagest Interactive Societe Anonyme reported unaudited sales results for the year ended December 31, 2013. For the period, the company's turnover was EUR 113.41 million compared to EUR 108.72 million a year ago. The structure of the PHARMAGEST Group's turnover in 2013 as well as the 100% integration in fourth quarter of its subsidiary HEALTHLEASE FRANCE makes it possible to anticipate a profit in 2013 as well as profitability that is increasing and greater than projected. For 2014, the PHARMAGEST Group already expects a significant impact on its Laboratories business as a result of regulatory changes. The decrease in turnover with low profit margin of this activity (Communication services), however, will have a mitigated effect on the operating income of the PHARMAGEST Group.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHA:FP €110.00 EUR +1.82

PHA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHA.
View Industry Companies
 

Industry Analysis

PHA

Industry Average

Valuation PHA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMAGEST INTERACTIVE, please visit www.pharmagest.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.